PMID: 15252271Jul 15, 2004Paper

Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease

Clinical Neuropharmacology
Valerie Voon, Anthony E Lang

Abstract

Psychotic symptoms are commonly associated with Parkinson disease and can be a source of significant morbidity. Depression has been reported as a comorbidity in patients with psychosis. We describe a patient with Parkinson disease with psychotic symptoms and comorbid depression whose treatment refractory delusions and hallucinations improved markedly only after antidepressant monotherapy was initiated. The phenomenology of the delusions was atypical for those found in Parkinson or in depression. Psychotic symptoms refractory or only partially responsive to conventional treatment should prompt a search for potential underlying psychiatric comorbidities. Given case reports of exacerbation of psychotic symptoms with antidepressants, we emphasize careful identification and active follow up of the comorbid depressive disorders in PD patients with psychosis. Potential mechanisms implicated in the response of psychosis to antidepressants are discussed.

References

Apr 1, 1996·The American Journal of Psychiatry·S Kapur, G Remington
Aug 7, 1998·Biological Psychiatry·I Lucki
Mar 29, 2000·Brain : a Journal of Neurology·G FénelonM Ziégler
Sep 1, 2000·Journal of the American Geriatrics Society·D AarslandK Laake
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·P J ReadingI G McKeith

❮ Previous
Next ❯

Citations

Sep 16, 2010·Current Treatment Options in Neurology·Laura B Zahodne, Hubert H Fernandez
Jul 31, 2008·Drugs & Aging·Laura B Zahodne, Hubert H Fernandez
Sep 22, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Dag AarslandAnette Schrag
Jan 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Dagmar VerbaanJacobus J van Hilten
Aug 6, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Kenji TagaiKazuhiko Nakayama
Aug 22, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Giuseppe Meco, Silvia Bernardi
Jan 15, 2015·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Jacopo Vittoriano BizzarriHans Peter Kapfhammer
Mar 27, 2015·Parkinson's Disease·Philippe HuotJonathan M Brotchie
Nov 11, 2016·Drugs & Aging·Niyatee SamudraShilpa Chitnis
Jun 15, 2007·Expert Review of Neurotherapeutics·Daniel Weintraub, Matthew B Stern
Jan 22, 2017·Journal of the Neurological Sciences·Karen Frei, Daniel D Truong
Apr 24, 2007·International Journal of Geriatric Psychiatry·Valerie VoonAnthony E Lang
Apr 28, 2006·Current Opinion in Psychiatry·Uwe Ehrt, Dag Aarsland
Jun 6, 2009·Nature Reviews. Neurology·Nico J DiederichChristopher G Goetz
Dec 15, 2012·Expert Review of Neurotherapeutics·Barbara S Connolly, Susan H Fox
Oct 11, 2014·Expert Review of Clinical Pharmacology·Martin BroadstockAnne Corbett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
Giuseppe Meco, Silvia Bernardi
Movement Disorders : Official Journal of the Movement Disorder Society
Nico J DiederichChristopher G Goetz
European Psychiatry : the Journal of the Association of European Psychiatrists
L Hosák, J Libiger
© 2022 Meta ULC. All rights reserved